| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.05 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |